Cargando…
Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China
IMPORTANCE: China, which has one-third of the worldwide smoking population, has a substantial cancer burden, with lung cancer being the leading cause of cancer-related death. The effectiveness of lung cancer screening for mortality reduction has been confirmed, but the cost-effectiveness of diverse...
Autores principales: | Zhao, Zixuan, Wang, Youqing, Wu, Weijia, Yang, Yi, Du, Lingbin, Dong, Hengjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131747/ https://www.ncbi.nlm.nih.gov/pubmed/35608858 http://dx.doi.org/10.1001/jamanetworkopen.2022.13634 |
Ejemplares similares
-
Cost-Effectiveness of Lung Cancer Screening Using Low-Dose Computed Tomography Based on Start Age and Interval in China: Modeling Study
por: Zhao, Zixuan, et al.
Publicado: (2022) -
Correction: Cost-Effectiveness of Lung Cancer Screening Using Low-Dose Computed Tomography Based on Start Age and Interval in China: Modeling Study
por: Zhao, Zixuan, et al.
Publicado: (2022) -
Preferred Lung Cancer Screening Modalities in China: A Discrete Choice Experiment
por: Zhao, Zixuan, et al.
Publicado: (2021) -
Modeling the Cost-effectiveness of Esophageal Cancer Screening in China
por: Li, Yuanyuan, et al.
Publicado: (2020) -
Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China
por: Guo, Lan-Wei, et al.
Publicado: (2020)